High-tech blood tests should replace ultrasound and other methods as the primary tools for screening for Down syndrome, argue researchers.
A single-molecule gene test requires much less DNA to identify cancer-causing mutations.
A molecular diagnosis gives doctors and patients better treatment options when suspicious lumps are found in the neck.
Now that genomes can be sequenced for $1,000, more patients can benefit, says Howard Jacob.
A new nerve interface gives a sense of touch to a prosthetic limb.
These VCs don’t wait for biotech startups to come to them. They create companies themselves.
After outflanking and outlasting competitors, it is on top of the genome-sequencing business—just as that market is about to soar in importance.
Researchers find a way to turn pain on, and off, with a beam of light.
Researchers are testing whether high-throughput DNA sequencing can help screen out abnormal embryos during in vitro fertilization.
Precise and easy ways to rewrite human genes could finally provide the tools that researchers need to understand and cure some of our most deadly genetic diseases.